Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardinal HealthLTS:0HTG -0.77%75 Days Sales Outstanding is 19.68 as of Jun. 2026, which is 1% below its 10-year median of 19.87. GuruFocus rates LTS:0HTG with a GF Score™ of 75/100 and a GF Value™ of $152.81 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 122 Medical Distribution companies, Cardinal Health ranks better than 95.9% on this metric.
Cardinal Health's average Accounts Receivable for the
three
months ended in Jun. 2026 was $13,732 Mil. Cardinal Health's Revenue for the
three
months ended in Jun. 2026 was $63,672 Mil.
Hence, Cardinal Health's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 19.68.
The historical rank and industry rank for Cardinal Health's Days Sales Outstanding or its related term are showing as below:
LTS:0HTG'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.66 Med: 19.87 Max: 21.7
Current: 19.56
During the past 13 years, Cardinal Health's highest Days Sales Outstanding was 21.70. The lowest was 18.66. And the median was 19.87.
LTS:0HTG's Days Sales Outstanding is ranked better than 95.9% of 122
companies
in the Medical Distribution industry
Industry Median: 77.93
vs LTS:0HTG: 19.56
Cardinal Health's Days Sales Outstanding
increased
from Jun. 2025 (19.65) to Jun. 2026 (19.68).
Cardinal Health (LTS:0HTG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Cardinal Health Days Sales Outstanding Related Terms
Cardinal Health Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Cardinal Health's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0HTG vs COR, HSIC, MCK: Days Sales Outstanding Comparison
For the Medical Distribution subindustry, Cardinal Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health Days Sales Outstanding vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cardinal Health's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Cardinal Health's Days Sales Outstanding falls into.
Cardinal Health Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardinal Health (LTS:0HTG) has a Days Sales Outstanding of 19.68 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Cardinal Health and its competitors. This is near median its historical median of 19.87. Over the past decade, Cardinal Health's Days Sales Outstanding has ranged from 18.66 to 21.70. According to the industry distribution chart, Cardinal Health ranks #5 out of 122 companies in the Medical Distribution industry, placing it in the top 4.1%.
Is Cardinal Health's Days Sales Outstanding too high?
Cardinal Health's current Days Sales Outstanding of 19.68 is near median its 10-year median of 19.87. Over the past 10 years, this metric has ranged from a low of 18.66 to a high of 21.70. The Medical Distribution industry median Days Sales Outstanding is 77.93. Cardinal Health's value of 19.68 is 74.7% below this industry median. Based on the distribution chart, Cardinal Health ranks #5 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cardinal Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Days Sales Outstanding compare to COR and HSIC?
According to the Medical Distribution industry distribution chart, Cardinal Health ranks #5 out of 122 companies for Days Sales Outstanding. This places Cardinal Health in the top 4% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 77.93. Cardinal Health's value of 19.68 is 74.7% below this benchmark. Historically, Cardinal Health's own Days Sales Outstanding has ranged from 18.66 to 21.70 over the past decade. While the company's 10-year median is 19.87 vs. the industry median of 77.93, Cardinal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Distribution company?
The median Days Sales Outstanding among Medical Distribution companies is 77.93, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardinal Health's current Days Sales Outstanding of 19.68 is 74.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Cardinal Health and its competitors. For the Medical Distribution industry, the median Days Sales Outstanding is 77.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardinal Health's current Days Sales Outstanding is 19.68, which is near median its own 10-year median of 19.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (LTS:0HTG) is currently considered Significantly Overvalued. The stock's GF Value™ is $152.81, compared to a current price of $225.84 — trading 47.8% above its estimated fair value. The current Days Sales Outstanding is 19.68, which is near median its 10-year median of 19.87 and 74.7% below the Medical Distribution industry median of 77.93. Cardinal Health's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Cardinal Health (LTS:0HTG), the current Days Sales Outstanding is 19.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (LTS:0HTG) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of $225.84 is trading 47.8% above its estimated GF Value™ of $152.81.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for LTS:0HTG:
Days Sales Outstanding: 19.68 (near median its 10-year median of 19.87)
GF Value™: $152.81 vs. price of $225.84 (47.8% above fair value)
Industry Position: 74.7% below the Medical Distribution median (#5 of 122)
No single metric tells the full story. See the LTS:0HTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
75GF Score
Get the complete analysis for LTS:0HTG
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HTG has been successfully added to your 
